DIRENZO, VITA
 Distribuzione geografica
Continente #
NA - Nord America 880
EU - Europa 102
AS - Asia 94
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 1.080
Nazione #
US - Stati Uniti d'America 880
CN - Cina 81
SE - Svezia 48
IT - Italia 18
FI - Finlandia 10
SG - Singapore 8
GB - Regno Unito 7
BE - Belgio 5
FR - Francia 4
DE - Germania 3
VN - Vietnam 3
EU - Europa 2
HK - Hong Kong 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
IE - Irlanda 1
MK - Macedonia 1
RO - Romania 1
UA - Ucraina 1
Totale 1.080
Città #
Fairfield 167
Woodbridge 145
Houston 74
Chandler 65
Seattle 65
Ashburn 61
Cambridge 49
Nyköping 40
Wilmington 38
Beijing 34
Ann Arbor 32
Jacksonville 16
Roxbury 12
Lawrence 11
Des Moines 9
Princeton 9
Brooklyn 8
Nanjing 8
Bari 7
Norwalk 7
Singapore 7
Dearborn 6
Boardman 5
Hebei 4
Inglewood 4
Jiaxing 4
Los Angeles 4
New York 4
Redwood City 4
San Diego 4
Shenyang 4
Brussels 3
Dong Ket 3
Shanghai 3
Tianjin 3
Andria 2
Hong Kong 2
Jesi 2
London 2
Marseille 2
Paris 2
Phoenix 2
Taranto 2
Waanrode 2
Wuhan 2
Brierley Hill 1
Changsha 1
Chengdu 1
Dublin 1
Guangzhou 1
Guiyang 1
Hangzhou 1
Hanover 1
Hefei 1
Indiana 1
Irvine 1
Jinan 1
Kansas City 1
Kunming 1
Lviv 1
New Bedfont 1
Ningbo 1
Quzhou 1
Santa Marinella 1
Sofia 1
Taizhou 1
Toledo 1
Trani 1
Totale 962
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 125
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta 118
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 105
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 105
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 101
A rare case of multiple sclerosis and McArdle disease 95
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 93
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 91
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 86
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis. 84
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis 79
null 65
Totale 1.147
Categoria #
all - tutte 4.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 19 6 34 32 24 26 41 38 28 50 6
2020/2021189 22 11 16 7 19 20 33 14 13 16 12 6
2021/2022103 3 10 0 0 6 15 4 3 10 12 20 20
2022/2023175 29 32 13 18 15 13 2 20 18 2 5 8
2023/202449 6 13 4 3 6 5 0 2 0 1 0 9
2024/202522 18 4 0 0 0 0 0 0 0 0 0 0
Totale 1.147